fashion -WSS

fashion

author：hotspot 2025-09-28 15:20:47 - browse：3

Sammy Kimball for STAT

Are drug prices protected by the Constitution? Will Medicare embrace Alzheimer’s disease treatments? And should lawyers be allowed to use thesauruses?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT Washington correspondent Rachel Cohrs joins us to explain Merck’s lawsuit against the federal government and why the company believes drug pricing negotiation is “tantamount to extortion.” We also discuss the health effects of Canadian wildfires, the highlights of the year’s biggest cancer research conference, and what could be a watershed moment in the treatment of Alzheimer’s.

For more on what we cover, here’s the latest on Merck; here’s more from ASCO; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： STAT Readout Newsletter: Biotech news today

WSS

Driven by the pandemic, applicants flood public health schools

Merck, Daiichi strike cancer drug pact worth up to $22 billion

The problems with dementia villages

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

Stanford president's case begs question: Who takes blame?

Cassava Sciences’ Alzheimer’s clinical trials should be halted

explore

fashion

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Questions loom on AstraZeneca cancer drug as safety concerns ebb

United colonoscopy coverage change 'may cost lives,' doctors say

Readout LOUD podcast: Live from the 2023 STAT Summit

Psychedelics group wrestles with new pharma identity

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

New air purifier tech could be key to improving indoor air quality

Judge rejects Trump's request to move Stormy Daniels hush

FDA approval of Sarepta Duchenne genetic therapy gives me hope

I learned firsthand about improving diversity in clinical trials

entertainment

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

DeSantis talks Trump, trans issues and 'what wokeness is'

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Merck, Daiichi strike cancer drug pact worth up to $22 billion

STAT Summit: Ending the crisis of Black deaths in the U.S.

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

knowledge

knowledge

hotspot

focus